Early diagnosis and angiographic exclusion of other causes of impaired blood flow are important in managing the no-reflow phenomenon after PCI.
Answers are grounded in this paper and cite their sources.
Supports vigilance for no-reflow after emergent PCI; leaves optimal strategies open for randomized trials.
The no-reflow phenomenon has been recognized as an uncommon complication after reperfusion therapy (thrombolytic or mechanical) for acute myocardial infarction and after percutaneous coronary intervention. As management and outcomes differ, early diagnosis and angiographic exclusion of other causes of impaired blood flow are important. The authors describe a case report of a patient with no-reflow following emergent stenting of the left circumflex artery (LCX). Pathophysiology and management of the no-reflow phenomenon are described along with the case report.
No takes yet. Share an insight, caveat, or question.
Safi et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: